@article{TCR9522,
author = {Cesare Gridelli and Tania Losanno},
title = {Afatinib and gefitinib: a direct comparison},
journal = {Translational Cancer Research},
volume = {5},
number = {Suppl 3},
year = {2016},
keywords = {},
abstract = {During the last decade, scientific literature had already reported data on frequency and characteristics of EGFR mutations among patients with non-small-cell lung cancer (NSCLC) and their response to tyrosine kinase inhibitors (TKIs) (1). Actually EGFR mutation-positive NSCLC is a well-defined molecular type of lung cancer with specific first-line treatment options.},
issn = {2219-6803}, url = {https://tcr.amegroups.org/article/view/9522}
}